MDS Nordion Appoints Christopher Wagner as Senior Vice-President of Sales and Marketing
30 Gennaio 2006 - 2:00PM
PR Newswire (US)
OTTAWA, Jan. 30 /PRNewswire-FirstCall/ -- MDS Nordion, a leading
supplier of radioisotopes, radiation and related technologies, is
pleased to announce the appointment of Christopher Wagner as Senior
Vice-President of Sales and Marketing. Mr. Wagner will report
directly to Steve West, President of MDS Nordion and will be a
member of the Executive Management Team. Mr. Wagner joins MDS
Nordion with nearly 30 years of global sales and marketing
experience, most recently with Tyco Healthcare/Mallinckrodt. Mr.
Wagner brings considerable knowledge in global strategic product
development and positioning. He is experienced in working with
large, multi-national companies and delivering strong sales and
marketing results. "Chris's extensive experience in the nuclear
medicine industry will help position us for growth, strengthen our
global franchise and build our product portfolios. His knowledge of
working with hospital and radiopharmacy operations, key industry
stakeholders and regulatory authorities will help us improve our
sales, marketing and business development efforts in a US$2.8
billion market," said Mr. West. Mr. Wagner holds a B.A. in Nuclear
Medicine from Otterbein College in Westerville, Ohio. He holds
several professional board certifications in radiology and nuclear
medicine, as well as a licensure in medical physics. "I am very
excited about joining the executive team at MDS Nordion and look
forward to better positioning the MDS Nordion strategic product
lines for growth. This is a vibrant organization with dedicated and
hard-working employees and it's motivating to be part of a company
that contributes to global health," said Mr. Wagner. MDS Nordion's
strategic product lines include medical isotopes for molecular
imaging, development and manufacturing of radiotherapeutics, and
sterilization products and services for the diagnosis, prevention
and treatment of disease. About MDS Nordion MDS Nordion
(http://www.mds.nordion.com/) is a world leader in radioisotopes,
radiation and related technologies. MDS Nordion is part of MDS Inc.
(TSX:MDS; NYSE:MDZ). MDS Inc. has more than 8,800 highly skilled
people in 28 countries. We provide a diverse range of superior
products and services to increase our customers' speed, precision
and productivity in the drug development and disease diagnosis
processes. We are a global, values-driven health and life sciences
company, recognized for our reliability and collaborative
relationships as we help create better outcomes in the treatment of
disease. Find out more at http://www.mdsintl.com/ or by calling
1-888-MDS-7222, 24 hours a day. Questions and Answers 1. What is
your background in the gamma industry and what kind of value do you
think you can add? - 30 years of global sales and marketing with
extensive knowledge and experience in: - Working with large,
multi-national customers, key industry stakeholders and regulatory
authorities around the world - Strategic product development and
positioning - Identifying business opportunities across multiple
product lines within global environment - Hospital and
radiopharmacy operations, regulatory jurisdictions and product
development cycle 2. Why did you leave Mallinckrodt to go to the
competitor? - MDS Nordion provided a personal growth opportunity
with a leadership role - Provides me with the opportunity to
position MDS Nordion's six strategic product lines for growth and
be more customer focused - Vibrant company with dedicated,
hard-working employees that contribute to global health-care 3. Are
there confidentiality concerns in your new role? - I believe in and
will follow the MDS Nordion core values: mutual trust, genuine
concern and respect for people, integrity, and commitment to
excellence 4. What changes are you planning to make to position MDS
Nordion for growth and success? - I want to better position each of
the six strategic product lines for growth - Be more customer
focused 5. Tyco recently announced they may split the Mallinckrodt
Inc. into three. Is hiring Christopher Wagner a strategic move
before acquiring part of the Mallinckrodt Inc. business? - Given
that we are a publicly traded company, and for confidentiality
reasons, I am unable to answer your question. DATASOURCE: MDS
Nordion CONTACT: Shelley Maclean, External Communications
Specialist, MDS Nordion, Tel: (613) 592-3400 ext. 2414, E-mail:
Copyright